NfL, a marker of neurodegeneration, has been reported to be released into the CSF and plasma in mouse models of neurodegenerative disease (Giacomucci et al, 2022) and in AP-4 patients (Alecu et al, 2023) but has not yet been investigated in AP-4 mouse models. The gene discussed is NEFL; the disease is neurodegenerative disease.